Differential sleep-promoting effects of dual orexin receptor antagonists and GABAAreceptor modulators-Reference-Cited by-同舟云学术

Differential sleep-promoting effects of dual orexin receptor antagonists and GABAAreceptor modulators

Published:2014-09-22 Issue:1 Volume:15 Page:
ISSN:1471-2202
Container-title:BMC Neuroscience
language:en
Short-container-title:BMC Neurosci

Author:

Gotter Anthony L,Garson Susan L,Stevens Joanne,Munden Regina L,Fox Steven V,Tannenbaum Pamela L,Yao Lihang,Kuduk Scott D,McDonald Terrence,Uslaner Jason M,Tye Spencer J,Coleman Paul J,Winrow Christopher J,Renger John J

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,General Neuroscience

Link

https://link.springer.com/content/pdf/10.1186/1471-2202-15-109.pdf

Reference50 articles.

1. Benca RM: Diagnosis and treatment of chronic insomnia: a review. Psychiatr Serv. 2005, 56: 332-343. 10.1176/appi.ps.56.3.332.

2. Roeh T, Roth T: Insomnia pharmacotherapy. Neurotherapeutics. 2012, 9: 728-738. 10.1007/s13311-012-0148-3.

3. Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M: Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008, 4: 487-504.

4. Wilson SJ, Nutt DJ, Alford C, Argyropoulos SV, Baldwin DS, Bateson AN, Britton TC, Crowe C, Dijk DJ, Espie CA, Gringras P, Hajak G, Idzikowski C, Krystal AD, Nash JR, Selsick H, Sharpley AL, Wade AG: British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol. 2010, 24: 1577-1601. 10.1177/0269881110379307.

5. Scammell TE, Winrow CJ: Orexin receptors: pharmacology and therapeutic opportunities. Annu Rev Pharmacol Toxicol. 2011, 51: 243-266. 10.1146/annurev-pharmtox-010510-100528.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of the initial administration of suvorexant on severe sleep apnea syndrome;Sleep and Biological Rhythms;2024-09-12

2. On the kinetic features of orexin receptor antagonists at orexin receptors, transduction systems and receptor binding;Medicine in Drug Discovery;2024-06

3. Daily treatment with the dual orexin receptor antagonist DORA-12 during oxycodone abstinence decreases oxycodone conditioned reinstatement;Neuropharmacology;2023-11

4. Efficacy and safety of Dimdazenil in adults with insomnia disorder: results from a multicenter, randomized, double-blind, placebo-controlled phase III trials;SLEEP;2023-10-24

5. Efficacy and safety of Dimdazenil in the adult insomnia patients: a phase II randomized, multicenter, double-blind, placebo-controlled, and parallel-group study;SLEEP;2023-10-21